Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
20:03
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

13th International Conference on Malignant Lymphoma

 

17-20 June 2015 Lugano
FAQs
   
Discussion forum - 13th International Conference on Malignant Lymphoma
    Topic - Hodgkin lymphoma

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder (HL-PTLD): A Comparative Analysis of Prognosis and Survival  Andrew Evens 1      6/9/2015 8:19:00 PM  
Healthcare utilization in the AETHERA trial: phase 3 study of brentuximab vedotin in patients at increased risk of residual Hodgkin lymphoma post ASCT  vijayveer bonthapally 1      6/9/2015 10:23:00 AM  
Role of bone marrow biopsy (BMB) in classic Hodgkin Lymphoma (cHL) staging in FDG-PET/CT era.  Benedetta Puccini 1      6/8/2015 11:44:00 PM  
Infradiaphragmatic Hodgkin Lymphoma: long term outcome improved by chemotherapy-radiotherapy VS chemotherapy alone.  Cédric rossi 1      6/8/2015 7:16:00 PM  
MYC and CHK1 Dependent Cell Death in T-cell Lymphoma and Hodgkin Lymphoma Cells and Human Xenograft Models With Anti-Proteasomal Therapy  Andrew Evens 1      6/8/2015 6:45:00 PM  
Hodgkin Lymphoma: PET-CT or bone marrow biopsy?  Zeinab Abou Yehia 1      6/8/2015 6:25:00 PM  
Pencil Beam Scanning Proton Therapy for Lymphoma Patients with Mediastinal Involvement: A Dosimetric Study and Preliminary Clinical Data  Katerina Dedeckova 1      6/7/2015 10:02:00 PM  
Consolidation radiation after ABVD is effective treatment for ed patients with Hodgkins lymphoma (HL) with interim PET positive scans.  Noelle ORourke 1      6/7/2015 4:21:00 PM  
Optimal Treatment Strategies for Early-Stage Hodgkins Lymphoma with B Symptoms and Bulky Disease at Presentation  Jay Reddy 1      6/6/2015 7:56:00 PM  
Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free time points and survival comparison to the general population in British Columbia.  Greg Hapgood 1      6/6/2015 7:05:00 AM  
Cardiac Radiation Dose and Predicted Cardiac Mortality in the UK RAPID Trial in Early Stage Hodgkin Lymphoma  David Cutter 1      6/5/2015 6:49:00 PM  
Efficacy and Safety of Lenalidomide and Rituximab vs Placebo and Rituximab in a Phase 3 Trial in Relapsed/Refractory Non-Hodgkin Lymphoma  John Leonard 1      6/4/2015 11:12:00 PM  
No survival benefit associated with routine imaging for classical Hodgkin lymphoma in complete remission: A Danish-Swedish population-based study  Tarec El-Galaly 1      6/4/2015 8:48:00 AM  
       




Most viewed poster for this congress
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center

Poster most viewed in this topic
Poster: 10
Visits: 365
Title: Efficacy and Safety of Lenalidomide and Rituximab vs Placebo and Rituximab in a Phase 3 Trial in Relapsed/Refractory Non-Hodgkin Lymphoma
Authors: John Leonard , Marek Trne&711;n, Phillip Scheinberg, Kensei Tobinai, Nathan H. Fowler, Nurgul Kilavuz, Pierre Fustier, Barbara Amoroso, and John G. Gribben
Centre: Weill Cornell Medical College,


 




PosterSessionOnline
Logo Draft
 
Logo Cert